Signia launches MaX AI hearing aid platform in Canada
Signia has launched its Multi-adaptive Xperience (MaX) hearing aid platform in Canada, using four Deep Neural Networks to analyze speech, noise, the listening environment, and the wearer’s own voice in real time. The first device, Pure C&G MaX, supports Bluetooth Classic, LE Audio, Telecoil, and Auracast connectivity. The launch expands Signia’s AI-powered hearing technology portfolio with a focus on real-time sound processing and connectivity.
Hedia secures MDR certification for pediatric diabetes care
Hedia has secured Medical Device Regulation (MDR) certification to expand its Hedia Diabetes Assistant to patients under 18. The update enables parents, caregivers, and healthcare teams to support pediatric diabetes management through the app and partner digital health platforms, while adding broader insulin regimen options and connectivity with CGMs, smart pens, smartwatches, and other mobile health platforms.
StimCardio reports positive NeuroPulse results for AF
StimCardio reported results from its NeuroPulse pilot study evaluating non-invasive median nerve stimulation following atrial fibrillation (AF) ablation. At six months, 90.0% of patients receiving stimulation remained free from atrial arrhythmias compared with 80.8% with sham treatment, while a sensitivity analysis showed fewer recurrent events with stimulation. The company plans to advance its investigational Rhyvive wearable device toward a pivotal trial.
